Anna S. Trigos
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancer.
Journal: Nature communications
Published: November 21, 2025
Sensitivity to immune checkpoint inhibitors in BRAF/MEK inhibitor refractory melanoma.
Journal: Journal for immunotherapy of cancer
Published: April 28, 2025
Examining CD103+ Tissue-Resident Memory T Cells in Nasopharyngeal Carcinoma.
Journal: Head & neck
Published: February 17, 2025
Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancer.
Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancer.
Journal: Nature communications
Published: February 05, 2025
How to get the most out of your cancer spatial transcriptomics data.
Journal: Seminars in cell & developmental biology
Published: November 25, 2024
Characterizing and Targeting of BCL-2 Family Members in Nasopharyngeal Carcinoma.
Journal: Head & neck
Published: April 03, 2024
Disruption of metazoan gene regulatory networks in cancer alters the balance of co-expression between genes of unicellular and multicellular origins.
Journal: Genome biology
Published: August 08, 2023
Comprehensive profiling identifies tumour and immune microenvironmental differences in clinical subsets of cutaneous squamous cell carcinoma.
Journal: The British journal of dermatology
Published: March 29, 2023
Copy number architectures define treatment-mediated selection of lethal prostate cancer clones.
Journal: Nature communications
Published: June 02, 2022
Last Updated: 09/26/2026